2022 Gene Therapy Market Worth US$ 3.44 Billion, Projected to Grow at 24% CAGR by 2030

Comments · 138 Views

The Global Gene Therapy Market accounted for close to US$ 3.44 billion by 2022 and is forecast to see growth at a compounded rate close to 24% over the period 2023-2030.

Astute Analytica has published an in-depth analysis of the Global Gene Therapy Market, offering a comprehensive overview of market dynamics, growth prospects, and emerging trends. The report meticulously examines the market landscape, including key drivers, challenges, opportunities, and the competitive strategies employed by leading players. As the market evolves, stakeholders can gain valuable insights into the factors shaping the industry and influencing its trajectory over the forecast period.

Market Values

The Global Gene Therapy Market accounted for close to US$ 3.44 billion by 2022 and is forecast to see growth at a compounded rate close to 24% over the period 2023-2030. The market growth is attributed to the increasing number of companies venturing into the market. Supporting the ongoing growth, the US FDA is estimating to receive more than 200 new applications to begin cell and gene therapy every year and approving 10-20 therapies every year by 2025.

A Request of this Sample PDF File@- https://www.astuteanalytica.com/request-sample/gene-therapy-market

The Promise of Gene Therapy

Gene therapy involves the introduction, removal, or alteration of genetic material within a patient's cells to treat or prevent disease. This innovative approach has shown immense promise in treating a range of conditions, including inherited genetic disorders, some types of cancer, and certain viral infections. The ability to correct defective genes at their source offers a potential cure for previously untreatable conditions, significantly improving patients' quality of life.

Segmentation Analysis

The Global Gene Therapy Market is segmented based on various parameters to provide a detailed analysis of the market structure and dynamics. The segmentation includes:

By Indication

  • Cancer
  • Cardiovascular Diseases
  • Hepatological Diseases
  • Infectious Disease
  • Neurological Disorders
  • Oncological Disorders
  • Rare Diseases
  • Others Diseases and Disorders

By Vector Type

  • Viral
    • Adenovirus
    • Adeno-associated Virus
    • Herpes Simplex Virus
    • Lentivirus
    • Poxvirus
    • Retrovirus
    • Vaccinia Virus
    • Others
  • Non-viral
    • Electroporation
    • Gene Gun
    • Naked Plasmid Vector
    • Lipofection
    • Others

By Gene Type

  • Antigen
  • Cytokine
  • Deficiency
  • Growth Factors
  • Receptors
  • Suicide Gene
  • Tumour Suppressor
  • Others

By Method of Delivery

  • Ex-vivo
  • In-vivo

This segmentation analysis enables stakeholders to identify high-growth segments and tailor their strategies to maximize their market presence and profitability.

For Purchase Enquiry: https://www.astuteanalytica.com/industry-report/gene-therapy-market

Key Players

The report identifies and profiles the leading players in the Global Gene Therapy Market, highlighting their market share, product portfolios, strategic initiatives, and recent developments. Some of the key players driving the market include:

Neurophth Therapeutics, Inc.

partners with AAVnerGene Inc.

Driving Factors Behind Market Growth

Several key factors are propelling the growth of the global gene therapy market:

  1. Advancements in Technology: Continuous advancements in genetic engineering technologies, such as CRISPR-Cas9 and other gene-editing tools, have made gene therapy more precise, efficient, and accessible.

  2. Increasing Prevalence of Genetic Disorders: The rising incidence of genetic disorders and chronic diseases worldwide is creating a substantial demand for innovative treatments like gene therapy.

  3. Regulatory Approvals and Collaborations: Increasing regulatory approvals for gene therapy products and strategic collaborations between pharmaceutical companies and research institutions are accelerating the development and commercialization of gene therapies.

  4. Growing Investment: Significant investments from both public and private sectors are fueling research and development activities in the gene therapy field.

  5. Patient Awareness and Acceptance: Greater awareness and acceptance among patients and healthcare providers about the benefits and potential of gene therapy are driving market adoption.

Notable Developments in Gene Therapy

The past few years have witnessed several groundbreaking developments in the gene therapy landscape:

  • Approval of Luxturna: Luxturna, developed by Spark Therapeutics, became the first FDA-approved gene therapy for an inherited genetic disorder. It treats a rare form of inherited blindness by delivering a normal copy of the RPE65 gene directly to retinal cells.

  • Advancements in CAR-T Therapy: Chimeric Antigen Receptor T-cell (CAR-T) therapy, a form of gene therapy used to treat certain types of cancer, has shown remarkable success rates in clinical trials. Products like Kymriah and Yescarta have been approved for the treatment of certain lymphomas and leukemias.

  • Expansion of Clinical Trials: A growing number of gene therapy clinical trials are underway, targeting a wide array of diseases, including hemophilia, muscular dystrophy, and cystic fibrosis.

Future Outlook

The future of the global gene therapy market looks exceptionally promising. With continuous advancements in genetic research, increased investment, and growing regulatory support, the market is poised for substantial growth. By 2030, the market is expected to reach new heights, potentially revolutionizing the treatment landscape for numerous genetic and chronic diseases.

Conclusion

The global gene therapy market is at the forefront of medical innovation, offering hope and healing to patients with previously untreatable conditions. As the market continues to grow at an impressive rate, driven by technological advancements, regulatory support, and increasing investment, the future of gene therapy looks bright. This transformative field holds the potential to redefine modern medicine and improve the lives of millions worldwide.

Download Sample PDF Report@- https://www.astuteanalytica.com/request-sample/gene-therapy-market

About Astute Analytica:

Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.

They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyse for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.

Get in touch with us

Phone number: +18884296757

Emailsales@astuteanalytica.com

Visit our websitehttps://www.astuteanalytica.com/

LinkedIn | Twitter | YouTube | Facebook | Pinterest

Comments